15/07/2024Published by Fondazione Gianni Bonadonna at 15/07/2024Categories Events UncategorizedOral SERD camizestrant in ER+, HER2- advanced breast cancer
08/07/2024Published by Fondazione Gianni Bonadonna at 08/07/2024Categories Events Uncategorized177Lu-Dotatate plus ocreotide as a first line therapy in neuroendocrine tumors
01/07/2024Published by Fondazione Gianni Bonadonna at 01/07/2024Categories Events UncategorizedOlaparib with or without bevacizumab in advanced colorectal cancer
24/06/2024Published by Fondazione Gianni Bonadonna at 24/06/2024Categories Events UncategorizedNeoadjuvant immunotherapy in advanced colon cancer
17/06/2024Published by Fondazione Gianni Bonadonna at 17/06/2024Categories Events UncategorizedArtificial intelligence in cancer research, a guide
10/06/2024Published by Fondazione Gianni Bonadonna at 10/06/2024Categories Events UncategorizedChemotherapy de-escalation in HER2+ early breast cancer
07/06/2024Published by Fondazione Gianni Bonadonna at 07/06/2024Categories Events UncategorizedA new call for applications for the international fellowship in honor of Gianni Bonadonna
03/06/2024Published by Fondazione Gianni Bonadonna at 03/06/2024Categories Events UncategorizedThe autologous T-cell therapy lifileucel in metastatic non-small cell lung cancer
27/05/2024Published by Fondazione Gianni Bonadonna at 27/05/2024Categories Events UncategorizedGiredestrant in HR+/HER2- advanced breast cancer
